drugset / Trial / NCT00930943

Effect of Extended-release Oxymorphone Taken With or Without Food on Cognitive Functioning

NCT00930943

Phase 4 Completed 30 enrolled MedVadis Research Corporation
RandomizedCrossoverSingle-blindTreatment

Summary

The purpose of the study is to determine whether extended-release oxymorphone hydrochloride taken orally with a high-fat meal, generating an approximately 50% higher Cmax, impacts cognitive functioning, using Cambridge Neuropsychological Test Automated Battery (CANTAB) tests, to a greater extent than when taking under conditions of fasting.

Timeline

Start
2009-05
Primary completion
2009-11
Completion
2009-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxymorphone Small molecule 40 mg Oral

Indications